Ortho-McNeil-Janssen Pharm. Inc.2

2014 Ark. 126
CourtSupreme Court of Arkansas
DecidedMarch 20, 2014
DocketCV-13-468
StatusPublished
Cited by2 cases

This text of 2014 Ark. 126 (Ortho-McNeil-Janssen Pharm. Inc.2) is published on Counsel Stack Legal Research, covering Supreme Court of Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ortho-McNeil-Janssen Pharm. Inc.2, 2014 Ark. 126 (Ark. 2014).

Opinion

Cite as 2014 Ark. 126

SUPREME COURT OF ARKANSAS No. CV-13-468

ORTHO-MCNEIL-JANSSEN Opinion Delivered March 20, 2014 PHARMACEUTICALS, INC., f/k/a JANSSEN PHARMACEUTICA, INC., APPEAL FROM THE PULASKI AND/OR JANSSEN, LP; and JOHNSON COUNTY CIRCUIT COURT & JOHNSON [NO. CV-2007-15345] APPELLANTS HONORABLE TIMOTHY DAVIS V. FOX, JUDGE

REVERSED AND REMANDED. STATE OF ARKANSAS APPELLEE

COURTNEY HUDSON GOODSON, Associate Justice

On January 31, 2013, the Pulaski County Circuit Court awarded $180,851,370 in

attorney’s fees and $298,799.86 in costs to the State as the prevailing party in Ortho-McNeil-

Janssen Pharmaceuticals, Inc. v. State, 2014 Ark. 124, ___ S.W.3d ___, Pulaski County Circuit

Court case number CV-2007-15345. For reversal, appellant Ortho-McNeil-Janssen

Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutica, Inc., and/or Janssen, LP, and Johnson &

Johnson (collectively referred to as “Janssen”) argues that (1) the State’s request for attorney’s

fees was premature because the “federal share” of the underlying judgment has not been

determined; (2) the court improperly interpreted the Medicaid Fraud and False Claims Act

(MFFCA) and the Arkansas Deceptive Trade Practices Act (ADTPA) as requiring courts to

shift contingency-fee agreements to the losing party; (3) the award does not comport with

Arkansas law regarding attorney’s fees because the circuit court based the fee award entirely Cite as 2014 Ark. 126

on the State’s contingency-fee agreement with Bailey Perrin Bailey (BPB); (4) the circuit

court improperly interpreted and applied the factors for determining an award of attorney’s

fees, as discussed in this court’s opinion in Chrisco v. Sun Industries, Inc., 304 Ark. 227, 800

S.W.2d 717 (1990); and (5) the attorney’s fee award violates the Excessive Fines and Due

Process Clauses of the United States and Arkansas Constitutions. This court’s jurisdiction is

proper as this is a companion case to the direct appeal in Ortho-McNeil-Janssen v. State, 2014

Ark. 124, ___ S.W.3d ___, handed down this same date, and because Janssen’s fee-shifting

argument presents an issue of first impression. Ark. Sup. Ct. R. 1-2(b)(1). Since the judgment

in favor of the State is reversed and dismissed in part on the MFFCA claim and reversed and

remanded on the ADTPA claim, the award of attorney’s fees is reversed and

remanded. Brookside Vill. Mobile Homes v. Meyers, 301 Ark. 139, 782 S.W.2d 365 (1990)

(reversing an award of attorney’s fees where the underlying judgment in favor of the

prevailing party was reversed).

Reversed and remanded.

O’Melveny &Myers, LLP, by: Charles C. Lifland (California), Stephen D. Brody and Walter Dellinger (Washington DC); Drinker Biddle & Reath LLP, by: Thomas F. Campion (New Jersey), Edward M. Posner, Gregg W. Mackuse (Pennsylvania); and Friday, Eldredge & Clark, LLP, by: James M. Simpson, Laura H. Smith, Robert S. Shafer, and Martin A. Kasten, for appellants.

Dustin McDaniel, Att’y Gen., by: Bradford J. Phelps, Chief Deputy Att’y Gen.; Kellogg, Huber, Hansen, Todd, Evans & Figel, PLLC, by: David C. Frederick, Derek T. Ho, and Caitlin S. Hall; and Bailey Perrin Bailey PLLC, by: Fletcher V. Trammell, Robert W. Cowan, Justin C. Jenson, and Elizabeth W. Dwyer, for appellee.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. State
2014 Ark. 124 (Supreme Court of Arkansas, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
2014 Ark. 126, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ortho-mcneil-janssen-pharm-inc2-ark-2014.